Overall Status

Completed (21)

Recruiting (4)

Active, not recruiting (2)

Enrolling by invitation (1)

Suspended (1)

Terminated (1)

Phase

phase 2 (9)

phase 1 (7)

phase 1/phase 2 (7)

n/a (5)

phase 3 (2)

Sponsor

Fred Hutchinson Cancer Center (19)

National Cancer Institute (NCI) (3)

University of Washington (2)

Ascentage Pharma Group Inc. (1)

Astex Pharmaceuticals, Inc. (1)

JW Pharmaceutical (1)

Martin, Paul (1)

Onconova Therapeutics, Inc. (1)

S*BIO (1)

Collaborator

National Cancer Institute (NCI) (18)

National Heart, Lung, and Blood Institute (NHLBI) (5)

HighPass Bio, Inc. (1)

The Leukemia and Lymphoma Society (1)

medac GmbH (1)

Study Documents

Intervention Type

drug (28)

other (18)

procedure (16)

radiation (14)

biological (10)

genetic (1)

Funder Type

Other (22)

Industry (5)

NIH (3)

Study Type

Interventional (30)

chronic myelomonocytic leukemia

Showing NaN - NaN of 30

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED